-
3
-
-
84869468683
-
Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis
-
Houlihan C.F., Larke N.L., Watson-Jones D., Smith-McCune K.K., Shiboski S., Gravitt P.E., Smith J.S., Kuhn L., Wang C., Hayes R. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. Aids 2012, 26:2211-2222.
-
(2012)
Aids
, vol.26
, pp. 2211-2222
-
-
Houlihan, C.F.1
Larke, N.L.2
Watson-Jones, D.3
Smith-McCune, K.K.4
Shiboski, S.5
Gravitt, P.E.6
Smith, J.S.7
Kuhn, L.8
Wang, C.9
Hayes, R.10
-
4
-
-
34247520467
-
Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues
-
Corey L. Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues. J. Infect. Dis. 2007, 195:1242-1244.
-
(2007)
J. Infect. Dis.
, vol.195
, pp. 1242-1244
-
-
Corey, L.1
-
5
-
-
84876206641
-
A review of clinical trials of human papillomavirus prophylactic vaccines
-
Schiller J.T., Castellsague X., Garland S.M. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012, 30(Suppl. 5):F123-F138.
-
(2012)
Vaccine
, vol.30
, pp. F123-F138
-
-
Schiller, J.T.1
Castellsague, X.2
Garland, S.M.3
-
7
-
-
84890117418
-
Prioritizing multipurpose prevention technology development and investments using a target product profile
-
Romano J., Manning J., Hemmerling A., McGrory E., Holt B.Y. Prioritizing multipurpose prevention technology development and investments using a target product profile. Antivir. Res. 2013, 100(Suppl.):S32-S38.
-
(2013)
Antivir. Res.
, vol.100
, pp. S32-S38
-
-
Romano, J.1
Manning, J.2
Hemmerling, A.3
McGrory, E.4
Holt, B.Y.5
-
8
-
-
33847249013
-
Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1
-
Hladik F., Sakchalathorn P., Ballweber L., Lentz G., Fialkow M., Eschenbach D., McElrath M.J. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007, 26:257-270.
-
(2007)
Immunity
, vol.26
, pp. 257-270
-
-
Hladik, F.1
Sakchalathorn, P.2
Ballweber, L.3
Lentz, G.4
Fialkow, M.5
Eschenbach, D.6
McElrath, M.J.7
-
9
-
-
33845803152
-
Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells
-
Bobardt M.D., Chatterji U., Selvarajah S., Van der Schueren B., David G., Kahn B., Gallay P.A. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 2007, 81:395-405.
-
(2007)
J. Virol.
, vol.81
, pp. 395-405
-
-
Bobardt, M.D.1
Chatterji, U.2
Selvarajah, S.3
Van der Schueren, B.4
David, G.5
Kahn, B.6
Gallay, P.A.7
-
10
-
-
37749011272
-
Resolution of de novo HIV production and trafficking in immature dendritic cells
-
Turville S.G., Aravantinou M., Stossel H., Romani N., Robbiani M. Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat. Methods 2008, 5:75-85.
-
(2008)
Nat. Methods
, vol.5
, pp. 75-85
-
-
Turville, S.G.1
Aravantinou, M.2
Stossel, H.3
Romani, N.4
Robbiani, M.5
-
12
-
-
79959817797
-
HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target
-
Martinelli E., Tharinger H., Frank I., Arthos J., Piatak M., Lifson J.D., Blanchard J., Gettie A., Robbiani M. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog. 2011, 7:e1002109.
-
(2011)
PLoS Pathog.
, vol.7
, pp. e1002109
-
-
Martinelli, E.1
Tharinger, H.2
Frank, I.3
Arthos, J.4
Piatak, M.5
Lifson, J.D.6
Blanchard, J.7
Gettie, A.8
Robbiani, M.9
-
13
-
-
84891703277
-
The frequency of alpha(4)beta(7)(high) memory CD4(+) T cells correlates with susceptibility to rectal simian immunodeficiency virus infection
-
Martinelli E., Veglia F., Goode D., Guerra-Perez N., Aravantinou M., Arthos J., Piatak M., Lifson J.D., Blanchard J., Gettie A., Robbiani M. The frequency of alpha(4)beta(7)(high) memory CD4(+) T cells correlates with susceptibility to rectal simian immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. 2013, 64:325-331.
-
(2013)
J. Acquir. Immune Defic. Syndr.
, vol.64
, pp. 325-331
-
-
Martinelli, E.1
Veglia, F.2
Goode, D.3
Guerra-Perez, N.4
Aravantinou, M.5
Arthos, J.6
Piatak, M.7
Lifson, J.D.8
Blanchard, J.9
Gettie, A.10
Robbiani, M.11
-
14
-
-
73949112038
-
The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1
-
Cicala C., Martinelli E., McNally J.P., Goode D.J., Gopaul R., Hiatt J., Jelicic K., Kottilil S., Macleod K., O'Shea A., Patel N., Van Ryk D., Wei D., Pascuccio M., Yi L., McKinnon L., Izulla P., Kimani J., Kaul R., Fauci A.S., Arthos J. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20877-20882.
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 20877-20882
-
-
Cicala, C.1
Martinelli, E.2
McNally, J.P.3
Goode, D.J.4
Gopaul, R.5
Hiatt, J.6
Jelicic, K.7
Kottilil, S.8
Macleod, K.9
O'Shea, A.10
Patel, N.11
Van Ryk, D.12
Wei, D.13
Pascuccio, M.14
Yi, L.15
McKinnon, L.16
Izulla, P.17
Kimani, J.18
Kaul, R.19
Fauci, A.S.20
Arthos, J.21
more..
-
15
-
-
0037651593
-
HIV-1 coreceptor usage, transmission, and disease progression
-
Philpott S.M. HIV-1 coreceptor usage, transmission, and disease progression. Curr. HIV Res. 2003, 1:217-227.
-
(2003)
Curr. HIV Res.
, vol.1
, pp. 217-227
-
-
Philpott, S.M.1
-
16
-
-
77955930318
-
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
-
Abdool Karim Q., Abdool Karim S.S., Frohlich J.A., Grobler A.C., Baxter C., Mansoor L.E., Kharsany A.B., Sibeko S., Mlisana K.P., Omar Z., Gengiah T.N., Maarschalk S., Arulappan N., Mlotshwa M., Morris L., Taylor D. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168-1174.
-
(2010)
Science
, vol.329
, pp. 1168-1174
-
-
Abdool Karim, Q.1
Abdool Karim, S.S.2
Frohlich, J.A.3
Grobler, A.C.4
Baxter, C.5
Mansoor, L.E.6
Kharsany, A.B.7
Sibeko, S.8
Mlisana, K.P.9
Omar, Z.10
Gengiah, T.N.11
Maarschalk, S.12
Arulappan, N.13
Mlotshwa, M.14
Morris, L.15
Taylor, D.16
-
17
-
-
84868521229
-
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection
-
Aravantinou M., Singer R., Derby N., Calenda G., Mawson P., Abraham C.J., Menon R., Seidor S., Goldman D., Kenney J., Villegas G., Gettie A., Blanchard J., Lifson J.D., Piatak M., Fernandez-Romero J.A., Zydowsky T.M., Teleshova N., Robbiani M. The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT Infection. AIDS Res. Hum. Retrovir. 2012, 28:1467-1475.
-
(2012)
AIDS Res. Hum. Retrovir.
, vol.28
, pp. 1467-1475
-
-
Aravantinou, M.1
Singer, R.2
Derby, N.3
Calenda, G.4
Mawson, P.5
Abraham, C.J.6
Menon, R.7
Seidor, S.8
Goldman, D.9
Kenney, J.10
Villegas, G.11
Gettie, A.12
Blanchard, J.13
Lifson, J.D.14
Piatak, M.15
Fernandez-Romero, J.A.16
Zydowsky, T.M.17
Teleshova, N.18
Robbiani, M.19
-
18
-
-
84907908413
-
A MIV-150/Zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants
-
Barnable P., Calenda G., Ouattara L.A., Gettie A., Blanchard J., Jean-Pierre N., Kizima L., Rodríguez A., Abraham C.J., Menon R., Seidor S., Cooney M.L., Roberts K.D., Sperling R., Piatak M., Lifson J.D., Fernández-Romero J.A., Zydowsky T.M., Robbiani M., Teleshova N. A MIV-150/Zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants. PLoS ONE 2014, 9(9):e108109.
-
(2014)
PLoS ONE
, vol.9
, Issue.9
, pp. e108109
-
-
Barnable, P.1
Calenda, G.2
Ouattara, L.A.3
Gettie, A.4
Blanchard, J.5
Jean-Pierre, N.6
Kizima, L.7
Rodríguez, A.8
Abraham, C.J.9
Menon, R.10
Seidor, S.11
Cooney, M.L.12
Roberts, K.D.13
Sperling, R.14
Piatak, M.15
Lifson, J.D.16
Fernández-Romero, J.A.17
Zydowsky, T.M.18
Robbiani, M.19
Teleshova, N.20
more..
-
19
-
-
84885348700
-
Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410
-
Buckheit R.W., Watson Buckheit K., Sturdevant C.B., Buckheit R.W. Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410. Antivir. Res. 2013, 100:382-391.
-
(2013)
Antivir. Res.
, vol.100
, pp. 382-391
-
-
Buckheit, R.W.1
Watson Buckheit, K.2
Sturdevant, C.B.3
Buckheit, R.W.4
-
20
-
-
59849088564
-
Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models
-
Buffa V., Stieh D., Mamhood N., Hu Q., Fletcher P., Shattock R.J. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models. J. Gen. Virol. 2009, 90:234-243.
-
(2009)
J. Gen. Virol.
, vol.90
, pp. 234-243
-
-
Buffa, V.1
Stieh, D.2
Mamhood, N.3
Hu, Q.4
Fletcher, P.5
Shattock, R.J.6
-
21
-
-
84868519069
-
Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits
-
Clark M.R., Friend D.R. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits. AIDS Res. Hum. Retrovir. 2012, 28:1458-1466.
-
(2012)
AIDS Res. Hum. Retrovir.
, vol.28
, pp. 1458-1466
-
-
Clark, M.R.1
Friend, D.R.2
-
22
-
-
79960417636
-
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates
-
Denton P.W., Othieno F., Martinez-Torres F., Zou W., Krisko J.F., Fleming E., Zein S., Powell D.A., Wahl A., Kwak Y.T., Welch B.D., Kay M.S., Payne D.A., Gallay P., Appella E., Estes J.D., Lu M., Garcia J.V. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J. Virol. 2011, 85:7582-7593.
-
(2011)
J. Virol.
, vol.85
, pp. 7582-7593
-
-
Denton, P.W.1
Othieno, F.2
Martinez-Torres, F.3
Zou, W.4
Krisko, J.F.5
Fleming, E.6
Zein, S.7
Powell, D.A.8
Wahl, A.9
Kwak, Y.T.10
Welch, B.D.11
Kay, M.S.12
Payne, D.A.13
Gallay, P.14
Appella, E.15
Estes, J.D.16
Lu, M.17
Garcia, J.V.18
-
23
-
-
84889888338
-
Development of dapivirine vaginal ring for HIV prevention
-
Devlin B., Nuttall J., Wilder S., Woodsong C., Rosenberg Z. Development of dapivirine vaginal ring for HIV prevention. Antivir. Res. 2013, 100(Suppl.):S3-S8.
-
(2013)
Antivir. Res.
, vol.100
, pp. S3-S8
-
-
Devlin, B.1
Nuttall, J.2
Wilder, S.3
Woodsong, C.4
Rosenberg, Z.5
-
24
-
-
84864385142
-
Reformulated tenofovir gel for use as a dual compartment microbicide
-
Dezzutti C.S., Rohan L.C., Wang L., Uranker K., Shetler C., Cost M., Lynam J.D., Friend D. Reformulated tenofovir gel for use as a dual compartment microbicide. J. Antimicrob. Chemother. 2012, 67:2139-2142.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 2139-2142
-
-
Dezzutti, C.S.1
Rohan, L.C.2
Wang, L.3
Uranker, K.4
Shetler, C.5
Cost, M.6
Lynam, J.D.7
Friend, D.8
-
25
-
-
33845997440
-
Carrageenan/MIV-150 (PC-815), a combination microbicide
-
Fernandez-Romero J.A., Thorn M., Turville S.G., Titchen K., Sudol K., Li J., Miller T., Robbiani M., Maguire R.A., Buckheit R.W., Hartman T.L., Phillips D.M. Carrageenan/MIV-150 (PC-815), a combination microbicide. Sex. Transm. Dis. 2007, 34:9-14.
-
(2007)
Sex. Transm. Dis.
, vol.34
, pp. 9-14
-
-
Fernandez-Romero, J.A.1
Thorn, M.2
Turville, S.G.3
Titchen, K.4
Sudol, K.5
Li, J.6
Miller, T.7
Robbiani, M.8
Maguire, R.A.9
Buckheit, R.W.10
Hartman, T.L.11
Phillips, D.M.12
-
26
-
-
23844482064
-
The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells
-
Fletcher P., Kiselyeva Y., Wallace G., Romano J., Griffin G., Margolis L., Shattock R. The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells. J. Virol. 2005, 79:11179-11186.
-
(2005)
J. Virol.
, vol.79
, pp. 11179-11186
-
-
Fletcher, P.1
Kiselyeva, Y.2
Wallace, G.3
Romano, J.4
Griffin, G.5
Margolis, L.6
Shattock, R.7
-
27
-
-
84869234019
-
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis
-
Johnson T.J., Clark M.R., Albright T.H., Nebeker J.S., Tuitupou A.L., Clark J.T., Fabian J., McCabe R.T., Chandra N., Doncel G.F., Friend D.R., Kiser P.F. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrob. Agents Chemother. 2012, 56:6272-6283.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 6272-6283
-
-
Johnson, T.J.1
Clark, M.R.2
Albright, T.H.3
Nebeker, J.S.4
Tuitupou, A.L.5
Clark, J.T.6
Fabian, J.7
McCabe, R.T.8
Chandra, N.9
Doncel, G.F.10
Friend, D.R.11
Kiser, P.F.12
-
28
-
-
84868581069
-
A single dose of a MIV-150/Zinc acetate gel provides 24h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24h after gel use
-
Kenney J., Singer R., Derby N., Aravantinou M., Abraham C.J., Menon R., Seidor S., Zhang S., Gettie A., Blanchard J., Piatak M., Lifson J.D., Fernandez-Romero J.A., Zydowsky T.M., Robbiani M. A single dose of a MIV-150/Zinc acetate gel provides 24h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24h after gel use. AIDS Res. Hum. Retrovir. 2012, 28:1476-1484.
-
(2012)
AIDS Res. Hum. Retrovir.
, vol.28
, pp. 1476-1484
-
-
Kenney, J.1
Singer, R.2
Derby, N.3
Aravantinou, M.4
Abraham, C.J.5
Menon, R.6
Seidor, S.7
Zhang, S.8
Gettie, A.9
Blanchard, J.10
Piatak, M.11
Lifson, J.D.12
Fernandez-Romero, J.A.13
Zydowsky, T.M.14
Robbiani, M.15
-
29
-
-
84899721240
-
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV
-
Kizima L., Rodriguez A., Kenney J., Derby N., Mizenina O., Menon R., Seidor S., Zhang S., Levendosky K., Jean-Pierre N., Pugach P., Villegas G., Ford B.E., Gettie A., Blanchard J., Piatak M., Lifson J.D., Paglini G., Teleshova N., Zydowsky T.M., Robbiani M., Fernandez-Romero J.A. A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS ONE 2014, 9:e94547.
-
(2014)
PLoS ONE
, vol.9
, pp. e94547
-
-
Kizima, L.1
Rodriguez, A.2
Kenney, J.3
Derby, N.4
Mizenina, O.5
Menon, R.6
Seidor, S.7
Zhang, S.8
Levendosky, K.9
Jean-Pierre, N.10
Pugach, P.11
Villegas, G.12
Ford, B.E.13
Gettie, A.14
Blanchard, J.15
Piatak, M.16
Lifson, J.D.17
Paglini, G.18
Teleshova, N.19
Zydowsky, T.M.20
Robbiani, M.21
Fernandez-Romero, J.A.22
more..
-
30
-
-
20144370949
-
Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp
-
Mori T., O'Keefe B.R., Sowder R.C., Bringans S., Gardella R., Berg S., Cochran P., Turpin J.A., Buckheit R.W., McMahon J.B., Boyd M.R. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem. 2005, 280:9345-9353.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 9345-9353
-
-
Mori, T.1
O'Keefe, B.R.2
Sowder, R.C.3
Bringans, S.4
Gardella, R.5
Berg, S.6
Cochran, P.7
Turpin, J.A.8
Buckheit, R.W.9
McMahon, J.B.10
Boyd, M.R.11
-
31
-
-
84455192446
-
Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques
-
Nuttall J., Kashuba A., Wang R., White N., Allen P., Roberts J., Romano J. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques. Antimicrob. Agents Chemother. 2012, 56:103-109.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 103-109
-
-
Nuttall, J.1
Kashuba, A.2
Wang, R.3
White, N.4
Allen, P.5
Roberts, J.6
Romano, J.7
-
32
-
-
40549106089
-
Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7days
-
Nuttall J.P., Thake D.C., Lewis M.G., Ferkany J.W., Romano J.W., Mitchnick M.A. Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7days. Antimicrob. Agents Chemother. 2008, 52:909-914.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 909-914
-
-
Nuttall, J.P.1
Thake, D.C.2
Lewis, M.G.3
Ferkany, J.W.4
Romano, J.W.5
Mitchnick, M.A.6
-
33
-
-
65549099593
-
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
-
O'Keefe B.R., Vojdani F., Buffa V., Shattock R.J., Montefiori D.C., Bakke J., Mirsalis J., d'Andrea A.L., Hume S.D., Bratcher B., Saucedo C.J., McMahon J.B., Pogue G.P., Palmer K.E. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6099-6104.
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 6099-6104
-
-
O'Keefe, B.R.1
Vojdani, F.2
Buffa, V.3
Shattock, R.J.4
Montefiori, D.C.5
Bakke, J.6
Mirsalis, J.7
d'Andrea, A.L.8
Hume, S.D.9
Bratcher, B.10
Saucedo, C.J.11
McMahon, J.B.12
Pogue, G.P.13
Palmer, K.E.14
-
34
-
-
84898645158
-
MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection
-
Ouattara L.A., Barnable P., Mawson P., Seidor S., Zydowsky T.M., Kizima L., Rodriguez A., Fernandez-Romero J.A., Cooney M.L., Roberts K.D., Gettie A., Blanchard J., Robbiani M., Teleshova N. MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection. Antimicrob. Agents Chemother. 2014, 58:2841-2848.
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 2841-2848
-
-
Ouattara, L.A.1
Barnable, P.2
Mawson, P.3
Seidor, S.4
Zydowsky, T.M.5
Kizima, L.6
Rodriguez, A.7
Fernandez-Romero, J.A.8
Cooney, M.L.9
Roberts, K.D.10
Gettie, A.11
Blanchard, J.12
Robbiani, M.13
Teleshova, N.14
-
35
-
-
77949532283
-
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide
-
Rohan L.C., Moncla B.J., Kunjara Na Ayudhya R.P., Cost M., Huang Y., Gai F., Billitto N., Lynam J.D., Pryke K., Graebing P., Hopkins N., Rooney J.F., Friend D., Dezzutti C.S. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS ONE 2010, 5:e9310.
-
(2010)
PLoS ONE
, vol.5
, pp. e9310
-
-
Rohan, L.C.1
Moncla, B.J.2
Kunjara Na Ayudhya, R.P.3
Cost, M.4
Huang, Y.5
Gai, F.6
Billitto, N.7
Lynam, J.D.8
Pryke, K.9
Graebing, P.10
Hopkins, N.11
Rooney, J.F.12
Friend, D.13
Dezzutti, C.S.14
-
36
-
-
84865986541
-
An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques
-
Singer R., Mawson P., Derby N., Rodriguez A., Kizima L., Menon R., Goldman D., Kenney J., Aravantinou M., Seidor S., Gettie A., Blanchard J., Piatak M., Lifson J.D., Fernandez-Romero J.A., Robbiani M., Zydowsky T.M. An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques. Sci. Transl. Med. 2012, 4:150-153.
-
(2012)
Sci. Transl. Med.
, vol.4
, pp. 150-153
-
-
Singer, R.1
Mawson, P.2
Derby, N.3
Rodriguez, A.4
Kizima, L.5
Menon, R.6
Goldman, D.7
Kenney, J.8
Aravantinou, M.9
Seidor, S.10
Gettie, A.11
Blanchard, J.12
Piatak, M.13
Lifson, J.D.14
Fernandez-Romero, J.A.15
Robbiani, M.16
Zydowsky, T.M.17
-
37
-
-
84885068247
-
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges
-
Smith J.M., Rastogi R., Teller R.S., Srinivasan P., Mesquita P.M., Nagaraja U., McNicholl J.M., Hendry R.M., Dinh C.T., Martin A., Herold B.C., Kiser P.F. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:16145-16150.
-
(2013)
Proc. Natl. Acad. Sci. U. S. A.
, vol.110
, pp. 16145-16150
-
-
Smith, J.M.1
Rastogi, R.2
Teller, R.S.3
Srinivasan, P.4
Mesquita, P.M.5
Nagaraja, U.6
McNicholl, J.M.7
Hendry, R.M.8
Dinh, C.T.9
Martin, A.10
Herold, B.C.11
Kiser, P.F.12
-
38
-
-
0742272702
-
Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models
-
Tsai C.C., Emau P., Jiang Y., Agy M.B., Shattock R.J., Schmidt A., Morton W.R., Gustafson K.R., Boyd M.R. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retrovir. 2004, 20:11-18.
-
(2004)
AIDS Res. Hum. Retrovir.
, vol.20
, pp. 11-18
-
-
Tsai, C.C.1
Emau, P.2
Jiang, Y.3
Agy, M.B.4
Shattock, R.J.5
Schmidt, A.6
Morton, W.R.7
Gustafson, K.R.8
Boyd, M.R.9
-
39
-
-
51849135855
-
Chapter 60 Herpes simplex viruses
-
Lippincott Williams & Wilkins, Philadelphia, PA, D.M. Knipe, P. Howley (Eds.)
-
Knipe D.M., Howley P. Chapter 60 Herpes simplex viruses. Fields Virology 2013, 1823-1897. Lippincott Williams & Wilkins, Philadelphia, PA. Sixth ed. D.M. Knipe, P. Howley (Eds.).
-
(2013)
Fields Virology
, pp. 1823-1897
-
-
Knipe, D.M.1
Howley, P.2
-
40
-
-
78149231880
-
Chapter 54 Papillomaviruses
-
Lippincott Williams & Wilkins, Philadelphia, PA, D.M. Knipe, P. Howley (Eds.)
-
Howley P.M., Schiller J.T. Chapter 54 Papillomaviruses. Fields Virology 2013, 1662-1703. Lippincott Williams & Wilkins, Philadelphia, PA. Sixth ed. D.M. Knipe, P. Howley (Eds.).
-
(2013)
Fields Virology
, pp. 1662-1703
-
-
Howley, P.M.1
Schiller, J.T.2
-
41
-
-
84879831306
-
Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types
-
Cruz L., Meyers C. Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS ONE 2013, 8:e68379.
-
(2013)
PLoS ONE
, vol.8
, pp. e68379
-
-
Cruz, L.1
Meyers, C.2
-
43
-
-
70349558085
-
Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events
-
Marshall B.C., Koch W.C. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events. Paediatr. Drugs 2009, 11:309-321.
-
(2009)
Paediatr. Drugs
, vol.11
, pp. 309-321
-
-
Marshall, B.C.1
Koch, W.C.2
-
44
-
-
78649435148
-
Preclinical evaluation of anti-HIV microbicide products: new models and biomarkers
-
Doncel G.F., Clark M.R. Preclinical evaluation of anti-HIV microbicide products: new models and biomarkers. Antivir. Res. 2010, 88(Suppl. 1):S10-S18.
-
(2010)
Antivir. Res.
, vol.88
, pp. S10-S18
-
-
Doncel, G.F.1
Clark, M.R.2
-
45
-
-
84857135720
-
Non-specific microbicide product development: then and now
-
Romano J.W., Robbiani M., Doncel G.F., Moench T. Non-specific microbicide product development: then and now. Curr. HIV Res. 2012, 10:9-18.
-
(2012)
Curr. HIV Res.
, vol.10
, pp. 9-18
-
-
Romano, J.W.1
Robbiani, M.2
Doncel, G.F.3
Moench, T.4
-
46
-
-
84905396254
-
Electrospun solid dispersions of maraviroc for rapid intravaginal pre-exposure prophylaxis of HIV
-
Ball C., Woodrow K.A. Electrospun solid dispersions of maraviroc for rapid intravaginal pre-exposure prophylaxis of HIV. Antimicrob Agents Chemother 2014.
-
(2014)
Antimicrob Agents Chemother
-
-
Ball, C.1
Woodrow, K.A.2
-
47
-
-
84881255827
-
Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues
-
Massud I., Aung W., Martin A., Bachman S., Mitchell J., Aubert R., Solomon Tsegaye T., Kersh E., Pau C.P., Heneine W., Garcia-Lerma J.G. Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues. J. Virol. 2013, 87:8952-8961.
-
(2013)
J. Virol.
, vol.87
, pp. 8952-8961
-
-
Massud, I.1
Aung, W.2
Martin, A.3
Bachman, S.4
Mitchell, J.5
Aubert, R.6
Solomon Tsegaye, T.7
Kersh, E.8
Pau, C.P.9
Heneine, W.10
Garcia-Lerma, J.G.11
-
48
-
-
79960990935
-
Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate
-
Kouokam J.C., Huskens D., Schols D., Johannemann A., Riedell S.K., Walter W., Walker J.M., Matoba N., O'Keefe B.R., Palmer K.E. Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate. PLoS ONE 2011, 6:e22635.
-
(2011)
PLoS ONE
, vol.6
, pp. e22635
-
-
Kouokam, J.C.1
Huskens, D.2
Schols, D.3
Johannemann, A.4
Riedell, S.K.5
Walter, W.6
Walker, J.M.7
Matoba, N.8
O'Keefe, B.R.9
Palmer, K.E.10
-
49
-
-
84890879718
-
Antibody-based concepts for multipurpose prevention technologies
-
(Suppl.)
-
Whaley K.J., Zeitlin L. Antibody-based concepts for multipurpose prevention technologies. Antivir. Res. 2013, 100:S48-S53. (Suppl.).
-
(2013)
Antivir. Res.
, vol.100
, pp. S48-S53
-
-
Whaley, K.J.1
Zeitlin, L.2
-
51
-
-
84893451859
-
A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge
-
Hsu M., Aravantinou M., Menon R., Seidor S., Goldman D., Kenney J., Derby N., Gettie A., Blanchard J., Piatak M., Lifson J.D., Fernandez-Romero J.A., Zydowsky T.M., Robbiani M. A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge. AIDS Res. Hum. Retrovir. 2014, 30:174-183.
-
(2014)
AIDS Res. Hum. Retrovir.
, vol.30
, pp. 174-183
-
-
Hsu, M.1
Aravantinou, M.2
Menon, R.3
Seidor, S.4
Goldman, D.5
Kenney, J.6
Derby, N.7
Gettie, A.8
Blanchard, J.9
Piatak, M.10
Lifson, J.D.11
Fernandez-Romero, J.A.12
Zydowsky, T.M.13
Robbiani, M.14
-
52
-
-
84897824849
-
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques
-
Hsu M., Keele B.F., Aravantinou M., Krawczyk N., Seidor S., Abraham C.J., Zhang S., Rodriguez A., Kizima L., Derby N., Jean-Pierre N., Mizenina O., Gettie A., Grasperge B., Blanchard J., Piatak M.J., Lifson J.D., Fernandez-Romero J.A., Zydowsky T.M., Robbiani M. Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques. PLoS ONE 2014, 9:e89300.
-
(2014)
PLoS ONE
, vol.9
, pp. e89300
-
-
Hsu, M.1
Keele, B.F.2
Aravantinou, M.3
Krawczyk, N.4
Seidor, S.5
Abraham, C.J.6
Zhang, S.7
Rodriguez, A.8
Kizima, L.9
Derby, N.10
Jean-Pierre, N.11
Mizenina, O.12
Gettie, A.13
Grasperge, B.14
Blanchard, J.15
Piatak, M.J.16
Lifson, J.D.17
Fernandez-Romero, J.A.18
Zydowsky, T.M.19
Robbiani, M.20
more..
-
53
-
-
79251589325
-
An antiretroviral/zinc combination gel provides 24hours of complete protection against vaginal SHIV infection in macaques
-
Kenney J., Aravantinou M., Singer R., Hsu M., Rodriguez A., Kizima L., Abraham C.J., Menon R., Seidor S., Chudolij A., Gettie A., Blanchard J., Lifson J.D., Piatak M., Fernandez-Romero J.A., Zydowsky T.M., Robbiani M. An antiretroviral/zinc combination gel provides 24hours of complete protection against vaginal SHIV infection in macaques. PLoS ONE 2011, 6:e15835.
-
(2011)
PLoS ONE
, vol.6
, pp. e15835
-
-
Kenney, J.1
Aravantinou, M.2
Singer, R.3
Hsu, M.4
Rodriguez, A.5
Kizima, L.6
Abraham, C.J.7
Menon, R.8
Seidor, S.9
Chudolij, A.10
Gettie, A.11
Blanchard, J.12
Lifson, J.D.13
Piatak, M.14
Fernandez-Romero, J.A.15
Zydowsky, T.M.16
Robbiani, M.17
-
54
-
-
84893493151
-
Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety
-
Nixon B., Jandl T., Teller R.S., Taneva E., Wang Y., Nagaraja U., Kiser P.F., Herold B.C. Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety. Antimicrob. Agents Chemother. 2014, 58:1153-1160.
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 1153-1160
-
-
Nixon, B.1
Jandl, T.2
Teller, R.S.3
Taneva, E.4
Wang, Y.5
Nagaraja, U.6
Kiser, P.F.7
Herold, B.C.8
-
55
-
-
84875226786
-
Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781
-
McConville C., Friend D. Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781. Eur. J. Pharm. Biopharm. 2013, 83:322-329.
-
(2013)
Eur. J. Pharm. Biopharm.
, vol.83
, pp. 322-329
-
-
McConville, C.1
Friend, D.2
-
56
-
-
84897502032
-
Postexposure protection of macaques from Vaginal SHIV infection by topical integrase inhibitors
-
Dobard C., Sharma S., Parikh U.M., West R., Taylor A., Martin A., Pau C.P., Hanson D.L., Lipscomb J., Smith J., Novembre F., Hazuda D., Garcia-Lerma J.G., Heneine W. Postexposure protection of macaques from Vaginal SHIV infection by topical integrase inhibitors. Sci. Transl. Med. 2014, 6:227-235.
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 227-235
-
-
Dobard, C.1
Sharma, S.2
Parikh, U.M.3
West, R.4
Taylor, A.5
Martin, A.6
Pau, C.P.7
Hanson, D.L.8
Lipscomb, J.9
Smith, J.10
Novembre, F.11
Hazuda, D.12
Garcia-Lerma, J.G.13
Heneine, W.14
-
57
-
-
0001771921
-
Herpes simplex viruses
-
Public Health Association, Washington, DC, N. Schmidt, R. Emmons (Eds.)
-
Ashley R. Herpes simplex viruses. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections 1995, 375-395. Public Health Association, Washington, DC. Seventh ed. N. Schmidt, R. Emmons (Eds.).
-
(1995)
Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections
, pp. 375-395
-
-
Ashley, R.1
-
58
-
-
84880293565
-
A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo
-
Kenney J., Rodriguez A., Kizima L., Seidor S., Menon R., Jean-Pierre N., Pugach P., Levendosky K., Derby N., Gettie A., Blanchard J., Piatak M., Lifson J.D., Paglini G., Zydowsky T.M., Robbiani M., Fernandez Romero J.A. A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo. Antimicrob. Agents Chemother. 2013, 57:4001-4009.
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 4001-4009
-
-
Kenney, J.1
Rodriguez, A.2
Kizima, L.3
Seidor, S.4
Menon, R.5
Jean-Pierre, N.6
Pugach, P.7
Levendosky, K.8
Derby, N.9
Gettie, A.10
Blanchard, J.11
Piatak, M.12
Lifson, J.D.13
Paglini, G.14
Zydowsky, T.M.15
Robbiani, M.16
Fernandez Romero, J.A.17
-
59
-
-
80052045748
-
Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro
-
Begay O., Jean-Pierre N., Abraham C.J., Chudolij A., Seidor S., Rodriguez A., Ford B.E., Henderson M., Katz D., Zydowsky T., Robbiani M., Fernandez-Romero J.A. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res. Hum. Retrovir. 2011, 27:1019-1024.
-
(2011)
AIDS Res. Hum. Retrovir.
, vol.27
, pp. 1019-1024
-
-
Begay, O.1
Jean-Pierre, N.2
Abraham, C.J.3
Chudolij, A.4
Seidor, S.5
Rodriguez, A.6
Ford, B.E.7
Henderson, M.8
Katz, D.9
Zydowsky, T.10
Robbiani, M.11
Fernandez-Romero, J.A.12
-
60
-
-
84455161700
-
Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge
-
Fernandez-Romero J.A., Abraham C.J., Rodriguez A., Kizima L., Jean-Pierre N., Menon R., Begay O., Seidor S., Ford B.E., Gil P.I., Peters J., Katz D., Robbiani M., Zydowsky T.M. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob. Agents Chemother. 2012, 56:358-368.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 358-368
-
-
Fernandez-Romero, J.A.1
Abraham, C.J.2
Rodriguez, A.3
Kizima, L.4
Jean-Pierre, N.5
Menon, R.6
Begay, O.7
Seidor, S.8
Ford, B.E.9
Gil, P.I.10
Peters, J.11
Katz, D.12
Robbiani, M.13
Zydowsky, T.M.14
-
61
-
-
69149100237
-
Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety
-
Mesquita P.M., Cheshenko N., Wilson S.S., Mhatre M., Guzman E., Fakioglu E., Keller M.J., Herold B.C. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J. Infect. Dis. 2009, 200:599-608.
-
(2009)
J. Infect. Dis.
, vol.200
, pp. 599-608
-
-
Mesquita, P.M.1
Cheshenko, N.2
Wilson, S.S.3
Mhatre, M.4
Guzman, E.5
Fakioglu, E.6
Keller, M.J.7
Herold, B.C.8
-
62
-
-
84861123517
-
Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model
-
Cost M., Dezzutti C.S., Clark M.R., Friend D.R., Akil A., Rohan L.C. Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model. Antimicrob. Agents Chemother. 2012, 56:3058-3066.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 3058-3066
-
-
Cost, M.1
Dezzutti, C.S.2
Clark, M.R.3
Friend, D.R.4
Akil, A.5
Rohan, L.C.6
-
63
-
-
84883905705
-
The preparation of a preclinical dossier to support an investigational new drug (IND) application and first-in-human clinical trial
-
Academic Press, San Diego, CA, A.S. Faqi (Ed.)
-
Faqi A.S. The preparation of a preclinical dossier to support an investigational new drug (IND) application and first-in-human clinical trial. A Comprehensive Guide to Toxicology in Preclinical Drug Development 2013, 309-333. Academic Press, San Diego, CA. A.S. Faqi (Ed.).
-
(2013)
A Comprehensive Guide to Toxicology in Preclinical Drug Development
, pp. 309-333
-
-
Faqi, A.S.1
-
65
-
-
84873717819
-
Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities
-
Dezzutti C.S., Hladik F. Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities. Curr. HIV/AIDS Rep. 2013, 10:12-20.
-
(2013)
Curr. HIV/AIDS Rep.
, vol.10
, pp. 12-20
-
-
Dezzutti, C.S.1
Hladik, F.2
-
66
-
-
42949112963
-
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides
-
Lackman-Smith C., Osterling C., Luckenbaugh K., Mankowski M., Snyder B., Lewis G., Paull J., Profy A., Ptak R.G., Buckheit R.W., Watson K.M., Cummins J.E., Sanders-Beer B.E. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother. 2008, 52:1768-1781.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 1768-1781
-
-
Lackman-Smith, C.1
Osterling, C.2
Luckenbaugh, K.3
Mankowski, M.4
Snyder, B.5
Lewis, G.6
Paull, J.7
Profy, A.8
Ptak, R.G.9
Buckheit, R.W.10
Watson, K.M.11
Cummins, J.E.12
Sanders-Beer, B.E.13
-
67
-
-
0030820343
-
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA
-
Meyers C., Mayer T.J., Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 1997, 71:7381-7386.
-
(1997)
J. Virol.
, vol.71
, pp. 7381-7386
-
-
Meyers, C.1
Mayer, T.J.2
Ozbun, M.A.3
-
68
-
-
0026671476
-
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation
-
Meyers C., Frattini M.G., Hudson J.B., Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992, 257:971-973.
-
(1992)
Science
, vol.257
, pp. 971-973
-
-
Meyers, C.1
Frattini, M.G.2
Hudson, J.B.3
Laimins, L.A.4
-
69
-
-
33746601451
-
Carrageenan is a potent inhibitor of papillomavirus infection
-
Buck C.B., Thompson C.D., Roberts J.N., Muller M., Lowy D.R., Schiller J.T. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006, 2:e69.
-
(2006)
PLoS Pathog.
, vol.2
, pp. e69
-
-
Buck, C.B.1
Thompson, C.D.2
Roberts, J.N.3
Muller, M.4
Lowy, D.R.5
Schiller, J.T.6
-
70
-
-
84903218843
-
In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition
-
Rodriguez A., Kleinbeck K., Mizenina O., Kizima L., Levendosky K., Jean-Pierre N., Villegas G., Ford B.E., Cooney M.L., Teleshova N., Robbiani M., Herold B.C., Zydowsky T., Fernandez Romero J.A. In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition. Antivir. Res. 2014, 108C:88-93.
-
(2014)
Antivir. Res.
, vol.108C
, pp. 88-93
-
-
Rodriguez, A.1
Kleinbeck, K.2
Mizenina, O.3
Kizima, L.4
Levendosky, K.5
Jean-Pierre, N.6
Villegas, G.7
Ford, B.E.8
Cooney, M.L.9
Teleshova, N.10
Robbiani, M.11
Herold, B.C.12
Zydowsky, T.13
Fernandez Romero, J.A.14
-
71
-
-
0034033172
-
Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract
-
Collins K.B., Patterson B.K., Naus G.J., Landers D.V., Gupta P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 2000, 6:475-479.
-
(2000)
Nat. Med.
, vol.6
, pp. 475-479
-
-
Collins, K.B.1
Patterson, B.K.2
Naus, G.J.3
Landers, D.V.4
Gupta, P.5
-
72
-
-
34248325562
-
Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture
-
Cummins J.E., Guarner J., Flowers L., Guenthner P.C., Bartlett J., Morken T., Grohskopf L.A., Paxton L., Dezzutti C.S. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob. Agents Chemother. 2007, 51:1770-1779.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 1770-1779
-
-
Cummins, J.E.1
Guarner, J.2
Flowers, L.3
Guenthner, P.C.4
Bartlett, J.5
Morken, T.6
Grohskopf, L.A.7
Paxton, L.8
Dezzutti, C.S.9
-
73
-
-
59849112612
-
Use of human tissue explants to study human infectious agents
-
Grivel J.C., Margolis L. Use of human tissue explants to study human infectious agents. Nat. Protoc. 2009, 4:256-269.
-
(2009)
Nat. Protoc.
, vol.4
, pp. 256-269
-
-
Grivel, J.C.1
Margolis, L.2
-
74
-
-
0034034688
-
Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides
-
Greenhead P., Hayes P., Watts P.S., Laing K.G., Griffin G.E., Shattock R.J. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 2000, 74:5577-5586.
-
(2000)
J. Virol.
, vol.74
, pp. 5577-5586
-
-
Greenhead, P.1
Hayes, P.2
Watts, P.S.3
Laing, K.G.4
Griffin, G.E.5
Shattock, R.J.6
-
75
-
-
34447265494
-
Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections
-
Madan R.P., Mesquita P.M., Cheshenko N., Jing B., Shende V., Guzman E., Heald T., Keller M.J., Regen S.L., Shattock R.J., Herold B.C. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections. J. Virol. 2007, 81:7636-7646.
-
(2007)
J. Virol.
, vol.81
, pp. 7636-7646
-
-
Madan, R.P.1
Mesquita, P.M.2
Cheshenko, N.3
Jing, B.4
Shende, V.5
Guzman, E.6
Heald, T.7
Keller, M.J.8
Regen, S.L.9
Shattock, R.J.10
Herold, B.C.11
-
76
-
-
84862678558
-
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection
-
Mesquita P.M., Rastogi R., Segarra T.J., Teller R.S., Torres N.M., Huber A.M., Kiser P.F., Herold B.C. Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J. Antimicrob. Chemother. 2012, 67:1730-1738.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 1730-1738
-
-
Mesquita, P.M.1
Rastogi, R.2
Segarra, T.J.3
Teller, R.S.4
Torres, N.M.5
Huber, A.M.6
Kiser, P.F.7
Herold, B.C.8
-
77
-
-
59749098155
-
Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor
-
Fletcher P., Harman S., Azijn H., Armanasco N., Manlow P., Perumal D., de Bethune M.P., Nuttall J., Romano J., Shattock R. Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor. Antimicrob. Agents Chemother. 2009, 53:487-495.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 487-495
-
-
Fletcher, P.1
Harman, S.2
Azijn, H.3
Armanasco, N.4
Manlow, P.5
Perumal, D.6
de Bethune, M.P.7
Nuttall, J.8
Romano, J.9
Shattock, R.10
-
78
-
-
0036776324
-
Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system
-
Gupta P., Collins K.B., Ratner D., Watkins S., Naus G.J., Landers D.V., Patterson B.K. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 2002, 76:9868-9876.
-
(2002)
J. Virol.
, vol.76
, pp. 9868-9876
-
-
Gupta, P.1
Collins, K.B.2
Ratner, D.3
Watkins, S.4
Naus, G.J.5
Landers, D.V.6
Patterson, B.K.7
-
79
-
-
84900532147
-
Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides
-
Rollenhagen C., Lathrop M.J., Macura S.L., Doncel G.F., Asin S.N. Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides. Mucosal Immunol 2014.
-
(2014)
Mucosal Immunol
-
-
Rollenhagen, C.1
Lathrop, M.J.2
Macura, S.L.3
Doncel, G.F.4
Asin, S.N.5
-
80
-
-
2442428094
-
Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue
-
Hu Q., Frank I., Williams V., Santos J.J., Watts P., Griffin G.E., Moore J.P., Pope M., Shattock R.J. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 2004, 199:1065-1075.
-
(2004)
J. Exp. Med.
, vol.199
, pp. 1065-1075
-
-
Hu, Q.1
Frank, I.2
Williams, V.3
Santos, J.J.4
Watts, P.5
Griffin, G.E.6
Moore, J.P.7
Pope, M.8
Shattock, R.J.9
-
81
-
-
73649108902
-
Caveats associated with the use of human cervical tissue for HIV and microbicide research
-
Anderson D.J., Pudney J., Schust D.J. Caveats associated with the use of human cervical tissue for HIV and microbicide research. AIDS 2010, 24:1-4.
-
(2010)
AIDS
, vol.24
, pp. 1-4
-
-
Anderson, D.J.1
Pudney, J.2
Schust, D.J.3
-
82
-
-
84862792191
-
Testing of viscous anti-HIV microbicides using Lactobacillus
-
Moncla B.J., Pryke K., Rohan L.C., Yang H. Testing of viscous anti-HIV microbicides using Lactobacillus. J. Microbiol. Methods 2012, 88:292-296.
-
(2012)
J. Microbiol. Methods
, vol.88
, pp. 292-296
-
-
Moncla, B.J.1
Pryke, K.2
Rohan, L.C.3
Yang, H.4
-
83
-
-
84881262655
-
HIV drug resistance: problems and perspectives
-
Pennings P.S. HIV drug resistance: problems and perspectives. Infect. Dis. Rep. 2013, 5:e5.
-
(2013)
Infect. Dis. Rep.
, vol.5
, pp. e5
-
-
Pennings, P.S.1
-
84
-
-
68649117176
-
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women
-
Nel A.M., Coplan P., van de Wijgert J.H., Kapiga S.H., von Mollendorf C., Geubbels E., Vyankandondera J., Rees H.V., Masenga G., Kiwelu I., Moyes J., Smythe S.C. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. AIDS 2009, 23:1531-1538.
-
(2009)
AIDS
, vol.23
, pp. 1531-1538
-
-
Nel, A.M.1
Coplan, P.2
van de Wijgert, J.H.3
Kapiga, S.H.4
von Mollendorf, C.5
Geubbels, E.6
Vyankandondera, J.7
Rees, H.V.8
Masenga, G.9
Kiwelu, I.10
Moyes, J.11
Smythe, S.C.12
-
85
-
-
77957323094
-
Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel
-
Nel A.M., Smythe S.C., Habibi S., Kaptur P.E., Romano J.W. Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel. J. Acquir. Immune Defic. Syndr. 2010, 55:161-169.
-
(2010)
J. Acquir. Immune Defic. Syndr.
, vol.55
, pp. 161-169
-
-
Nel, A.M.1
Smythe, S.C.2
Habibi, S.3
Kaptur, P.E.4
Romano, J.W.5
-
86
-
-
84856074519
-
In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine
-
Schader S.M., Oliveira M., Ibanescu R.I., Moisi D., Colby-Germinario S.P., Wainberg M.A. In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine. Antimicrob. Agents Chemother. 2012, 56:751-756.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 751-756
-
-
Schader, S.M.1
Oliveira, M.2
Ibanescu, R.I.3
Moisi, D.4
Colby-Germinario, S.P.5
Wainberg, M.A.6
-
87
-
-
78349239340
-
Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse
-
Moench T.R., Mumper R.J., Hoen T.E., Sun M., Cone R.A. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect. Dis. 2010, 10:331.
-
(2010)
BMC Infect. Dis.
, vol.10
, pp. 331
-
-
Moench, T.R.1
Mumper, R.J.2
Hoen, T.E.3
Sun, M.4
Cone, R.A.5
-
88
-
-
73449131509
-
Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety
-
Wilson S.S., Cheshenko N., Fakioglu E., Mesquita P.M., Keller M.J., Herold B.C. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety. Antivir. Ther. 2009, 14:1113-1124.
-
(2009)
Antivir. Ther.
, vol.14
, pp. 1113-1124
-
-
Wilson, S.S.1
Cheshenko, N.2
Fakioglu, E.3
Mesquita, P.M.4
Keller, M.J.5
Herold, B.C.6
-
89
-
-
11144357239
-
Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides
-
Catalone B.J., Kish-Catalone T.M., Budgeon L.R., Neely E.B., Ferguson M., Krebs F.C., Howett M.K., Labib M., Rando R., Wigdahl B. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob. Agents Chemother. 2004, 48:1837-1847.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 1837-1847
-
-
Catalone, B.J.1
Kish-Catalone, T.M.2
Budgeon, L.R.3
Neely, E.B.4
Ferguson, M.5
Krebs, F.C.6
Howett, M.K.7
Labib, M.8
Rando, R.9
Wigdahl, B.10
-
90
-
-
80855144836
-
Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety
-
Segarra T.J., Fakioglu E., Cheshenko N., Wilson S.S., Mesquita P.M., Doncel G.F., Herold B.C. Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety. PLoS ONE 2011, 6:e27675.
-
(2011)
PLoS ONE
, vol.6
, pp. e27675
-
-
Segarra, T.J.1
Fakioglu, E.2
Cheshenko, N.3
Wilson, S.S.4
Mesquita, P.M.5
Doncel, G.F.6
Herold, B.C.7
-
91
-
-
33750337283
-
Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque
-
Patton D.L., Sweeney Y.T., Balkus J.E., Hillier S.L. Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque. Sex. Transm. Dis. 2006, 33:691-695.
-
(2006)
Sex. Transm. Dis.
, vol.33
, pp. 691-695
-
-
Patton, D.L.1
Sweeney, Y.T.2
Balkus, J.E.3
Hillier, S.L.4
-
92
-
-
33646449167
-
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model
-
Patton D.L., Cosgrove Sweeney Y.T., McCarthy T.D., Hillier S.L. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob. Agents Chemother. 2006, 50:1696-1700.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 1696-1700
-
-
Patton, D.L.1
Cosgrove Sweeney, Y.T.2
McCarthy, T.D.3
Hillier, S.L.4
-
93
-
-
1842429076
-
Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies
-
Patton D.L., Sweeney Y.C., Tsai C.C., Hillier S.L. Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies. J. Med. Primatol. 2004, 33:105-108.
-
(2004)
J. Med. Primatol.
, vol.33
, pp. 105-108
-
-
Patton, D.L.1
Sweeney, Y.C.2
Tsai, C.C.3
Hillier, S.L.4
-
94
-
-
84898636351
-
Pharmacokinetic and safety analyses of tenofovir and tenofovir-emtricitabine vaginal tablets in pigtailed macaques
-
Pereira L.E., Clark M.R., Friend D.R., Garber D.A., McNicholl J.M., Hendry R.M., Doncel G.F., Smith J.M. Pharmacokinetic and safety analyses of tenofovir and tenofovir-emtricitabine vaginal tablets in pigtailed macaques. Antimicrob. Agents Chemother. 2014, 58:2665-2674.
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 2665-2674
-
-
Pereira, L.E.1
Clark, M.R.2
Friend, D.R.3
Garber, D.A.4
McNicholl, J.M.5
Hendry, R.M.6
Doncel, G.F.7
Smith, J.M.8
-
95
-
-
84870748389
-
Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen
-
Radzio J., Aung W., Holder A., Martin A., Sweeney E., Mitchell J., Bachman S., Pau C.P., Heneine W., Garcia-Lerma J.G. Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. PLoS ONE 2012, 7:e50632.
-
(2012)
PLoS ONE
, vol.7
, pp. e50632
-
-
Radzio, J.1
Aung, W.2
Holder, A.3
Martin, A.4
Sweeney, E.5
Mitchell, J.6
Bachman, S.7
Pau, C.P.8
Heneine, W.9
Garcia-Lerma, J.G.10
-
96
-
-
84886711813
-
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention
-
Romano J., Kashuba A., Becker S., Cummins J., Turpin J., Veronese F. Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention. AIDS Res. Hum. Retrovir. 2013, 29:1418-1427.
-
(2013)
AIDS Res. Hum. Retrovir.
, vol.29
, pp. 1418-1427
-
-
Romano, J.1
Kashuba, A.2
Becker, S.3
Cummins, J.4
Turpin, J.5
Veronese, F.6
-
97
-
-
84866502506
-
Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation
-
Uglietti A., Zanaboni D., Gnarini M., Maserati R. Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation. Expert Opin. Drug Metab. Toxicol. 2012, 8:1305-1314.
-
(2012)
Expert Opin. Drug Metab. Toxicol.
, vol.8
, pp. 1305-1314
-
-
Uglietti, A.1
Zanaboni, D.2
Gnarini, M.3
Maserati, R.4
-
98
-
-
84886051506
-
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties
-
Mesquita P.M., Srinivasan P., Johnson T.J., Rastogi R., Evans-Strickfaden T., Kay M.S., Buckheit K.W., Buckheit R.W., Smith J.M., Kiser P.F., Herold B.C. Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties. Retrovirology 2013, 10:113.
-
(2013)
Retrovirology
, vol.10
, pp. 113
-
-
Mesquita, P.M.1
Srinivasan, P.2
Johnson, T.J.3
Rastogi, R.4
Evans-Strickfaden, T.5
Kay, M.S.6
Buckheit, K.W.7
Buckheit, R.W.8
Smith, J.M.9
Kiser, P.F.10
Herold, B.C.11
-
99
-
-
66149175684
-
Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring
-
Romano J., Variano B., Coplan P., Van Roey J., Douville K., Rosenberg Z., Temmerman M., Verstraelen H., Van Bortel L., Weyers S., Mitchnick M. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res. Hum. Retrovir. 2009, 25:483-488.
-
(2009)
AIDS Res. Hum. Retrovir.
, vol.25
, pp. 483-488
-
-
Romano, J.1
Variano, B.2
Coplan, P.3
Van Roey, J.4
Douville, K.5
Rosenberg, Z.6
Temmerman, M.7
Verstraelen, H.8
Van Bortel, L.9
Weyers, S.10
Mitchnick, M.11
-
100
-
-
0345471066
-
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
-
Veazey R.S., Shattock R.J., Pope M., Kirijan J.C., Jones J., Hu Q., Ketas T., Marx P.A., Klasse P.J., Burton D.R., Moore J.P. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 2003, 9:343-346.
-
(2003)
Nat. Med.
, vol.9
, pp. 343-346
-
-
Veazey, R.S.1
Shattock, R.J.2
Pope, M.3
Kirijan, J.C.4
Jones, J.5
Hu, Q.6
Ketas, T.7
Marx, P.A.8
Klasse, P.J.9
Burton, D.R.10
Moore, J.P.11
-
101
-
-
27744571425
-
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion
-
Veazey R.S., Klasse P.J., Schader S.M., Hu Q., Ketas T.J., Lu M., Marx P.A., Dufour J., Colonno R.J., Shattock R.J., Springer M.S., Moore J.P. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 2005, 438:99-102.
-
(2005)
Nature
, vol.438
, pp. 99-102
-
-
Veazey, R.S.1
Klasse, P.J.2
Schader, S.M.3
Hu, Q.4
Ketas, T.J.5
Lu, M.6
Marx, P.A.7
Dufour, J.8
Colonno, R.J.9
Shattock, R.J.10
Springer, M.S.11
Moore, J.P.12
-
102
-
-
28644432424
-
Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor
-
Veazey R.S., Springer M.S., Marx P.A., Dufour J., Klasse P.J., Moore J.P. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat. Med. 2005, 11:1293-1294.
-
(2005)
Nat. Med.
, vol.11
, pp. 1293-1294
-
-
Veazey, R.S.1
Springer, M.S.2
Marx, P.A.3
Dufour, J.4
Klasse, P.J.5
Moore, J.P.6
-
103
-
-
79959938249
-
High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques
-
Vishwanathan S.A., Guenthner P.C., Lin C.Y., Dobard C., Sharma S., Adams D.R., Otten R.A., Heneine W., Hendry R.M., McNicholl J.M., Kersh E.N. High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J. Acquir. Immune Defic. Syndr. 2011, 57:261-264.
-
(2011)
J. Acquir. Immune Defic. Syndr.
, vol.57
, pp. 261-264
-
-
Vishwanathan, S.A.1
Guenthner, P.C.2
Lin, C.Y.3
Dobard, C.4
Sharma, S.5
Adams, D.R.6
Otten, R.A.7
Heneine, W.8
Hendry, R.M.9
McNicholl, J.M.10
Kersh, E.N.11
-
104
-
-
70349736171
-
Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine
-
Parikh U.M., Dobard C., Sharma S., Cong M.E., Jia H., Martin A., Pau C.P., Hanson D.L., Guenthner P., Smith J., Kersh E., Garcia-Lerma J.G., Novembre F.J., Otten R., Folks T., Heneine W. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J. Virol. 2009, 83:10358-10365.
-
(2009)
J. Virol.
, vol.83
, pp. 10358-10365
-
-
Parikh, U.M.1
Dobard, C.2
Sharma, S.3
Cong, M.E.4
Jia, H.5
Martin, A.6
Pau, C.P.7
Hanson, D.L.8
Guenthner, P.9
Smith, J.10
Kersh, E.11
Garcia-Lerma, J.G.12
Novembre, F.J.13
Otten, R.14
Folks, T.15
Heneine, W.16
-
105
-
-
84863115647
-
Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue
-
Dobard C., Sharma S., Martin A., Pau C.P., Holder A., Kuklenyik Z., Lipscomb J., Hanson D.L., Smith J., Novembre F.J., Garcia-Lerma J.G., Heneine W. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J. Virol. 2012, 86:718-725.
-
(2012)
J. Virol.
, vol.86
, pp. 718-725
-
-
Dobard, C.1
Sharma, S.2
Martin, A.3
Pau, C.P.4
Holder, A.5
Kuklenyik, Z.6
Lipscomb, J.7
Hanson, D.L.8
Smith, J.9
Novembre, F.J.10
Garcia-Lerma, J.G.11
Heneine, W.12
-
106
-
-
80054955393
-
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
-
Lagenaur L.A., Sanders-Beer B.E., Brichacek B., Pal R., Liu X., Liu Y., Yu R., Venzon D., Lee P.P., Hamer D.H. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol. 2011, 4:648-657.
-
(2011)
Mucosal Immunol.
, vol.4
, pp. 648-657
-
-
Lagenaur, L.A.1
Sanders-Beer, B.E.2
Brichacek, B.3
Pal, R.4
Liu, X.5
Liu, Y.6
Yu, R.7
Venzon, D.8
Lee, P.P.9
Hamer, D.H.10
-
107
-
-
84861709262
-
Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice
-
Denton P.W., Garcia J.V. Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol. 2012, 20:268-274.
-
(2012)
Trends Microbiol.
, vol.20
, pp. 268-274
-
-
Denton, P.W.1
Garcia, J.V.2
-
108
-
-
84883870005
-
Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus
-
Hadas E., Chao W., He H., Saini M., Daley E., Saifuddin M., Bentsman G., Ganz E., Volsky D.J., Potash M.J. Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus. Dis. Model. Mech. 2013, 6:1292-1298.
-
(2013)
Dis. Model. Mech.
, vol.6
, pp. 1292-1298
-
-
Hadas, E.1
Chao, W.2
He, H.3
Saini, M.4
Daley, E.5
Saifuddin, M.6
Bentsman, G.7
Ganz, E.8
Volsky, D.J.9
Potash, M.J.10
-
109
-
-
0035039512
-
Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization
-
Maguire R.A., Bergman N., Phillips D.M. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex. Transm. Dis. 2001, 28:259-265.
-
(2001)
Sex. Transm. Dis.
, vol.28
, pp. 259-265
-
-
Maguire, R.A.1
Bergman, N.2
Phillips, D.M.3
-
110
-
-
0031724086
-
Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections
-
Maguire R.A., Zacharopoulos V.R., Phillips D.M. Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections. Sex. Transm. Dis. 1998, 25:494-500.
-
(1998)
Sex. Transm. Dis.
, vol.25
, pp. 494-500
-
-
Maguire, R.A.1
Zacharopoulos, V.R.2
Phillips, D.M.3
-
111
-
-
84878210806
-
Griffithsin protects mice from genital herpes by preventing cell-to-cell spread
-
Nixon B., Stefanidou M., Mesquita P.M., Fakioglu E., Segarra T., Rohan L., Halford W., Palmer K.E., Herold B.C. Griffithsin protects mice from genital herpes by preventing cell-to-cell spread. J. Virol. 2013, 87:6257-6269.
-
(2013)
J. Virol.
, vol.87
, pp. 6257-6269
-
-
Nixon, B.1
Stefanidou, M.2
Mesquita, P.M.3
Fakioglu, E.4
Segarra, T.5
Rohan, L.6
Halford, W.7
Palmer, K.E.8
Herold, B.C.9
-
112
-
-
33748419209
-
ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations
-
Tuyama A.C., Cheshenko N., Carlucci M.J., Li J.H., Goldberg C.L., Waller D.P., Anderson R.A., Profy A.T., Klotman M.E., Keller M.J., Herold B.C. ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J. Infect. Dis. 2006, 194:795-803.
-
(2006)
J. Infect. Dis.
, vol.194
, pp. 795-803
-
-
Tuyama, A.C.1
Cheshenko, N.2
Carlucci, M.J.3
Li, J.H.4
Goldberg, C.L.5
Waller, D.P.6
Anderson, R.A.7
Profy, A.T.8
Klotman, M.E.9
Keller, M.J.10
Herold, B.C.11
-
113
-
-
29744466672
-
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial
-
Keller M.J., Zerhouni-Layachi B., Cheshenko N., John M., Hogarty K., Kasowitz A., Goldberg C.L., Wallenstein S., Profy A.T., Klotman M.E., Herold B.C. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J. Infect. Dis. 2006, 193:27-35.
-
(2006)
J. Infect. Dis.
, vol.193
, pp. 27-35
-
-
Keller, M.J.1
Zerhouni-Layachi, B.2
Cheshenko, N.3
John, M.4
Hogarty, K.5
Kasowitz, A.6
Goldberg, C.L.7
Wallenstein, S.8
Profy, A.T.9
Klotman, M.E.10
Herold, B.C.11
-
114
-
-
38049074585
-
Seminal plasma reduces the effectiveness of topical polyanionic microbicides
-
Patel S., Hazrati E., Cheshenko N., Galen B., Yang H., Guzman E., Wang R., Herold B.C., Keller M.J. Seminal plasma reduces the effectiveness of topical polyanionic microbicides. J. Infect. Dis. 2007, 196:1394-1402.
-
(2007)
J. Infect. Dis.
, vol.196
, pp. 1394-1402
-
-
Patel, S.1
Hazrati, E.2
Cheshenko, N.3
Galen, B.4
Yang, H.5
Guzman, E.6
Wang, R.7
Herold, B.C.8
Keller, M.J.9
-
115
-
-
77951237291
-
A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy
-
Crostarosa F., Aravantinou M., Akpogheneta O.J., Jasny E., Shaw A., Kenney J., Piatak M., Lifson J.D., Teitelbaum A., Hu L., Chudolij A., Zydowsky T.M., Blanchard J., Gettie A., Robbiani M. A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy. PLoS ONE 2009, 4:e8060.
-
(2009)
PLoS ONE
, vol.4
, pp. e8060
-
-
Crostarosa, F.1
Aravantinou, M.2
Akpogheneta, O.J.3
Jasny, E.4
Shaw, A.5
Kenney, J.6
Piatak, M.7
Lifson, J.D.8
Teitelbaum, A.9
Hu, L.10
Chudolij, A.11
Zydowsky, T.M.12
Blanchard, J.13
Gettie, A.14
Robbiani, M.15
-
116
-
-
79953848750
-
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection
-
Tronstein E., Johnston C., Huang M.L., Selke S., Magaret A., Warren T., Corey L., Wald A. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011, 305:1441-1449.
-
(2011)
JAMA
, vol.305
, pp. 1441-1449
-
-
Tronstein, E.1
Johnston, C.2
Huang, M.L.3
Selke, S.4
Magaret, A.5
Warren, T.6
Corey, L.7
Wald, A.8
-
117
-
-
54749135281
-
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults
-
Mark K.E., Wald A., Magaret A.S., Selke S., Olin L., Huang M.L., Corey L. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J. Infect. Dis. 2008, 198:1141-1149.
-
(2008)
J. Infect. Dis.
, vol.198
, pp. 1141-1149
-
-
Mark, K.E.1
Wald, A.2
Magaret, A.S.3
Selke, S.4
Olin, L.5
Huang, M.L.6
Corey, L.7
-
118
-
-
84863176906
-
Associations between virologic and immunologic dynamics in blood and in the male genital tract
-
Gianella S., Strain M.C., Rought S.E., Vargas M.V., Little S.J., Richman D.D., Spina C.A., Smith D.M. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J. Virol. 2012, 86:1307-1315.
-
(2012)
J. Virol.
, vol.86
, pp. 1307-1315
-
-
Gianella, S.1
Strain, M.C.2
Rought, S.E.3
Vargas, M.V.4
Little, S.J.5
Richman, D.D.6
Spina, C.A.7
Smith, D.M.8
-
119
-
-
16944365192
-
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease
-
Boursnell M.E., Entwisle C., Blakeley D., Roberts C., Duncan I.A., Chisholm S.E., Martin G.M., Jennings R., Ni Challanain D., Sobek I., Inglis S.C., McLean C.S. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J. Infect. Dis. 1997, 175:16-25.
-
(1997)
J. Infect. Dis.
, vol.175
, pp. 16-25
-
-
Boursnell, M.E.1
Entwisle, C.2
Blakeley, D.3
Roberts, C.4
Duncan, I.A.5
Chisholm, S.E.6
Martin, G.M.7
Jennings, R.8
Ni Challanain, D.9
Sobek, I.10
Inglis, S.C.11
McLean, C.S.12
-
120
-
-
27744537436
-
The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies
-
Yim K.C., Carroll C.J., Tuyama A., Cheshenko N., Carlucci M.J., Porter D.D., Prince G.A., Herold B.C. The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies. J. Virol. 2005, 79:14632-14639.
-
(2005)
J. Virol.
, vol.79
, pp. 14632-14639
-
-
Yim, K.C.1
Carroll, C.J.2
Tuyama, A.3
Cheshenko, N.4
Carlucci, M.J.5
Porter, D.D.6
Prince, G.A.7
Herold, B.C.8
-
121
-
-
34447122482
-
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan
-
Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., Lowy D.R., Schiller J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13:857-861.
-
(2007)
Nat. Med.
, vol.13
, pp. 857-861
-
-
Roberts, J.N.1
Buck, C.B.2
Thompson, C.D.3
Kines, R.4
Bernardo, M.5
Choyke, P.L.6
Lowy, D.R.7
Schiller, J.T.8
-
122
-
-
79955770732
-
Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model
-
Roberts J.N., Kines R.C., Katki H.A., Lowy D.R., Schiller J.T. Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model. J. Natl. Cancer Inst. 2011, 103:737-743.
-
(2011)
J. Natl. Cancer Inst.
, vol.103
, pp. 737-743
-
-
Roberts, J.N.1
Kines, R.C.2
Katki, H.A.3
Lowy, D.R.4
Schiller, J.T.5
-
123
-
-
0014581047
-
Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys
-
Eckstein P., Jackson M.C., Millman N., Sobrero A.J. Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. J. Reprod. Fertil. 1969, 20:85-93.
-
(1969)
J. Reprod. Fertil.
, vol.20
, pp. 85-93
-
-
Eckstein, P.1
Jackson, M.C.2
Millman, N.3
Sobrero, A.J.4
-
124
-
-
7244257490
-
Preclinical assessment of the proinflammatory potential of microbicide candidates
-
Doncel G.F., Chandra N., Fichorova R.N. Preclinical assessment of the proinflammatory potential of microbicide candidates. J. Acquir. Immune Defic. Syndr. 2004, 37(Suppl. 3):S174-S180.
-
(2004)
J. Acquir. Immune Defic. Syndr.
, vol.37
, pp. S174-S180
-
-
Doncel, G.F.1
Chandra, N.2
Fichorova, R.N.3
-
125
-
-
67649935663
-
High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides
-
Vincent K.L., Bourne N., Bell B.A., Vargas G., Tan A., Cowan D., Stanberry L.R., Rosenthal S.L., Motamedi M. High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex. Transm. Dis. 2009, 36:312-318.
-
(2009)
Sex. Transm. Dis.
, vol.36
, pp. 312-318
-
-
Vincent, K.L.1
Bourne, N.2
Bell, B.A.3
Vargas, G.4
Tan, A.5
Cowan, D.6
Stanberry, L.R.7
Rosenthal, S.L.8
Motamedi, M.9
-
126
-
-
84897137511
-
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy
-
Clark J.T., Clark M.R., Shelke N.B., Johnson T.J., Smith E.M., Andreasen A.K., Nebeker J.S., Fabian J., Friend D.R., Kiser P.F. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy. PLoS ONE 2014, 9:e88509.
-
(2014)
PLoS ONE
, vol.9
, pp. e88509
-
-
Clark, J.T.1
Clark, M.R.2
Shelke, N.B.3
Johnson, T.J.4
Smith, E.M.5
Andreasen, A.K.6
Nebeker, J.S.7
Fabian, J.8
Friend, D.R.9
Kiser, P.F.10
-
127
-
-
75549087128
-
Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission
-
Nikolic D.S., Piguet V. Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission. J. Investig. Dermatol. 2010, 130:352-361.
-
(2010)
J. Investig. Dermatol.
, vol.130
, pp. 352-361
-
-
Nikolic, D.S.1
Piguet, V.2
|